SCRI-Colorado Blood Cancer Institute

Denver, Colorado 80218

2 studies enrolling now · 4 studies all time

What they study most

AML, Acute Myeloid Leukemia, MDS, Myelodysplastic Syndrome (MDS)

Studies at this site

• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• STIMULUS MDS-US : Sabatolimab Added to HMA in Higher Risk MDS — Stopped early
• Standard of Care +/- Midostaurin to Prevent Relapse Post Stem Cell Transplant in Patients With FLT3-ITD Mutated AML — Completed